Tumour inhibitory triazenes: Structural requirements for an active metabolite
- 1 February 1976
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 25 (3) , 241-246
- https://doi.org/10.1016/0006-2952(76)90207-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Isotope effects in O- and N-demethylations mediated by rat liver microsomes: An application of direct insertion electron impact mass spectrometryChemico-Biological Interactions, 1974
- Studies on the mechanism of action of the tumour inhibitory triazenesBiochemical Pharmacology, 1973
- Acylierung von Hydroxy‐phenyl‐triazenen, eine neuartige UmlagerungEuropean Journal of Organic Chemistry, 1973
- Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-caboxamide in mammalian cells in cultureBiochemical Pharmacology, 1972
- 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanomaPublished by Elsevier ,1972
- Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazeneJournal of Medicinal Chemistry, 1972
- Studies on the reversal of the selective antitumour effect of the aziridinyl derivative cb 1954 by 4‐amino‐5‐imidazolecarboxamideInternational Journal of Cancer, 1972
- Benzene Analogs of TriazenoirnidazolesJournal of Pharmaceutical Sciences, 1971
- 610. The possibility of geometrical isomerism among the 1-aryl-3 : 3-dimethyltriazensJournal of the Chemical Society, 1951
- 119. Union of aryl nuclei. Part VI. Reactions with 1-aryl-3 : 3-dimethyltriazensJournal of the Chemical Society, 1943